Related Experiment Video
Updated: May 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Functional impacts of the diversity of the meningococcal factor H binding protein
Eva Hong1, Dario Giorgini, Ala-Eddine Deghmane
1Institut Pasteur, Invasive Bacterial Infections Unit and National Reference Centre for Meningococci, 28 Rue du Dr Roux, 75724 Paris Cedex 15, France.
Abstract:
Neisseria meningitidis is a human pathogenic bacterium responsible for life threatening and rapidly evolving invasive infections. Several bacterial virulence factors may play primordial roles during host-bacteria interactions. The meningococcal factor H binding protein, fHbp, interacts with the complement negative regulator, factor H (fH), to enhance meningococcal survival. fHbp is a major component in recombinant vaccines against meningococci that are under development. In 2010, we detected variations in fhbp gene during an outbreak provoked by serogroup C isolates belonging to the clonal complex, ST-11. We therefore explored 680 meningococcal isolates (88% of all invasive isolates in 2009 and 2010) by DNA sequencing of fhbp gene. The level of fHbp at the bacterial surface was determined by ELISA and flow cytometry using anti-fHbp antibodies. We also analyzed the interaction of fHbp with human fH as well as the deposition of C3b complement component. We observed important sequence diversity of fHbp in particular within regions known to interact with fH. The distribution of fhbp alleles differed among meningococcal serogroups and clonal complexes. This diversity affected directly binding of fH to fHbp and seemed to influence the deposition of the complement C3b component on the bacterial surface. However, bacterial killing by anti-fHbp antibodies was still achieved and required a minimum level of fHbp at the bacterial surface regardless the binding to fH or sequence diversity. These data have impacts on our understanding of the role of fHbp in meningococcal pathogenesis. They also provide data on the diversity of fhbp before the introduction of vaccines targeting fHbp and stress the need to include characterization of fHbp in typing schemes of meningococcal isolates.
Insights
Meningococcal factor H binding protein (fHbp) shows significant genetic diversity, impacting its interaction with human factor H and complement C3b deposition. However, anti-fHbp antibodies effectively kill bacteria, requiring a minimum fHbp surface level.
Area of Science:
- Bacteriology
- Immunology
- Vaccine Development
Background:
- Neisseria meningitidis causes severe invasive infections.
- Meningococcal factor H binding protein (fHbp) aids bacterial survival by interacting with human factor H.
- fHbp is a key target for developing new meningococcal vaccines.
Purpose of the Study:
- To investigate the sequence diversity of the fhbp gene in Neisseria meningitidis.
- To assess the impact of fHbp diversity on factor H binding and complement deposition.
- To evaluate the efficacy of anti-fHbp antibodies in bacterial killing.
Main Methods:
- DNA sequencing of the fhbp gene from 680 meningococcal isolates.
- ELISA and flow cytometry to quantify surface fHbp levels.
- Analysis of fHbp-factor H interactions and C3b complement deposition.
Main Results:
- Significant sequence diversity in fHbp, particularly in factor H-binding regions.
- fHbp allele distribution varied across meningococcal serogroups and clonal complexes.
- Diversity affected factor H binding and C3b deposition, but anti-fHbp antibody-mediated killing remained effective above a threshold fHbp level.
Conclusions:
- fHbp sequence diversity influences meningococcal pathogenesis and immune evasion strategies.
- Characterizing fHbp diversity is crucial for understanding meningococcal evolution and vaccine efficacy.
- Minimum fHbp surface levels are essential for bacterial survival and antibody-mediated killing.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Bacterial Meningitis II: Pathophysiology
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...

